MAPT and amyloidosis: The use of multimodal imaging (Liang et al., 2023), such as combining MRI and fluorescence, could provide deeper insights into the spatial distribution of nanocarriers in the brain, potentially highlighting areas of amyloid plaque accumulation or tau pathology.